Is PCF undervalued? Our fair value estimate

High Income Securities Fund · Financial Services · NYQ

Our fair value estimate
USD6.66
Current share price
USD5.34
Upside to fair value
+24.7%
Screens as undervalued. High Income Securities Fund trades 25% below the USD6.66 our model puts on the business. A fair value estimate is an argument, not a measurement: it is only as good as its growth assumption, and the market is frequently right about why something trades where it does.
Overall rating: 61/100, BuyMoat score: 52/100Data quality: high confidence (88/100 of the inputs on file)

How we got here

The estimate is computed from PCF's reported fundamentals, with a growth assumption that is deliberately capped: small changes to an uncapped growth or terminal assumption can justify any price, and a number that can justify anything means nothing. These are the inputs the model holds for PCF today; the exact method, and where it goes wrong, is on the methodology page.

Earnings multiple25.3x

The starting point is earnings power: what the business earns per share, and what the market currently pays for each unit of it.

Revenue growth (YoY)-35.8%

The trailing growth rate informs the growth assumption, which the model caps deliberately: uncapped growth assumptions can justify any price.

Profit margin63.2%

Margins tell the model how much of each unit of revenue survives as profit, and how much room there is for that to erode.

Return on equity3.2%

Persistent high returns on capital are what a moat looks like in the accounts, and they feed the moat score alongside the valuation.

Beta0.65

A volatility measure against the wider market. A jumpier share earns a larger discount for risk, which lowers the estimate.

The belief gap: what growth this price asks you to believe

Run our DCF backwards and every price becomes a growth assumption. One axis compares them: today's market price, the entry prices implied by super investors' 13F filings, the mean analyst target, and the growth our own model funds. The gap between the market's marker and the cohort's markers is the growth you are being asked to believe that informed buyers did not need.

Citadel Advisors*3.2%Our model5.0%
0% growth12% annual cash-flow growth

No growth rate between 0% and 30% makes our model's fair value equal today's price, so the market is pricing something our DCF cannot express. Citadel Advisors's Q4 2025 entry underwrote about 3.2%. Our model funds 5.0%.

Citadel Advisors's Q4 2025 filing implies an average entry near $6.15, which implied about 3.2% annual growth under our model (low confidence).

Entry prices are filing-implied averages (reported position value divided by reported shares for the quarter a position was opened or materially increased), not actual cost bases; 13Fs lag by up to 45 days. How the Belief Gap is computed.

Common questions

Is High Income Securities Fund (PCF) undervalued?

On our model, PCF at USD5.34 trades 25% below our fair value estimate of USD6.66, so it screens as undervalued today. That is one model's answer, not a recommendation: a fair value estimate is an argument about the future, and the market is frequently right about why something is cheap.

What is the fair value of PCF?

Our current fair value estimate for High Income Securities Fund is USD6.66 per share. The estimate moves as prices and fundamentals move.

How is PCF's fair value calculated?

From High Income Securities Fund's reported fundamentals: earnings power, a deliberately capped growth assumption, and a discount for balance sheet and volatility risk. The full method, including its known weaknesses, is published on our methodology page, and the interactive Valuation Lab lets you change every assumption and watch the value move.

Disagree with an assumption? Good. The Valuation Lab on the PCF app page puts every input of this model on a slider, including a reverse DCF that shows the growth the market is currently pricing in.

A fair value estimate is a model output computed from company filings and market data, refreshed daily; quotes are delayed. It is educational information, not financial advice and not a recommendation to buy or sell anything. Read the full disclaimer.